INNOMIND Trademark

Trademark Overview


On Tuesday, January 23, 2024, a trademark application was filed for INNOMIND with the United States Patent and Trademark Office. The USPTO has given the INNOMIND trademark a serial number of 98372177. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 1, 2024. This trademark is owned by Luye Innomind Pharma Shijiazhuang Co., Ltd.. The INNOMIND trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, tumors, cardiovascular diseases, colds, coughs, influenza, respiratory disorders and asthma, gastrointestinal disorders, genitourinary disorders, neurological disorders, allergic reactions, headaches, insomnia, bacterial disorders and eye diseases; Chemical preparations for pharmaceutical purposes, namely, for neurological system related diseases and disorders; Biological preparations for the treatment of neurological system related diseases; Pharmaceutical products for the treatment of central nervous system related diseases; Pharmaceutical preparations for the prevention and treatment of neurological disorders; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical pr...
innomind

General Information


Serial Number98372177
Word MarkINNOMIND
Filing DateTuesday, January 23, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements


Goods and ServicesMedicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, tumors, cardiovascular diseases, colds, coughs, influenza, respiratory disorders and asthma, gastrointestinal disorders, genitourinary disorders, neurological disorders, allergic reactions, headaches, insomnia, bacterial disorders and eye diseases; Chemical preparations for pharmaceutical purposes, namely, for neurological system related diseases and disorders; Biological preparations for the treatment of neurological system related diseases; Pharmaceutical products for the treatment of central nervous system related diseases; Pharmaceutical preparations for the prevention and treatment of neurological disorders; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for peripheral nervous system; Tranquillizers; Cardiovascular pharmaceutical preparations; Antidepressants; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for treating diabetes; Ophthalmic preparations; Pain relief medication; Tumor suppressing agents; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLuye Innomind Pharma Shijiazhuang Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShijiazhuang city ShijiazhuangH.T.Zone
CN

Party NameLuye Innomind Pharma Shijiazhuang Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShijiazhuang city ShijiazhuangH.T.Zone
CN

Trademark Events


Event DateEvent Description
Tuesday, January 23, 2024NEW APPLICATION ENTERED
Friday, May 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 19, 2024ASSIGNED TO EXAMINER